Your browser doesn't support javascript.
loading
Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib.
Jiménez-Fonseca, Paula; Martín, Miguel Navarro; Carmona-Bayonas, Alberto; Calvo, Alfonso; Fernández-Mateos, Javier; Redrado, Miriam; Capdevila, Jaume; Lago, Nieves Martínez; Lacasta, Adelaida; Muñarriz, Javier; Segura, Ángel; Fuster, Josep; Barón, Francisco; Llanos, Marta; Serrano, Raquel; Castillo, Alfredo; Cruz Hernández, Juan Jesús; Grande, Enrique.
Afiliación
  • Jiménez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Martín MN; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain.
  • Calvo A; IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Department of Histology and Pathology, University of Navarra, CIBERONC, ISC-II, Pamplona, Spain.
  • Fernández-Mateos J; Molecular Medicine Unit, IBSAL, Department of Medicine, University of Salamanca, Salamanca, Spain.
  • Redrado M; IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Department of Histology and Pathology, University of Navarra, Pamplona, Navarra, Spain.
  • Capdevila J; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain.
  • Lago NM; Medical Oncology Department, Hospital Universitario de A Coruña, La Coruña, Spain.
  • Lacasta A; Medical Oncology Department, Hospital Universitario Donostia, Guipúzcoa, Spain.
  • Muñarriz J; Medical Oncology Department, Hospital General Universitario de Castellón, Castellón, Spain.
  • Segura Á; Medical Oncology Department, Hospital Universitario La Fe, Valencia, Spain.
  • Fuster J; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Barón F; Medical Oncology Department, Hospital Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Serrano R; Medical Oncology Department, Hospital Universitario Reina Sofia, Cordoba, Spain.
  • Castillo A; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Cruz Hernández JJ; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • Grande E; Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain.
Oncotarget ; 9(97): 36894-36905, 2018 Dec 11.
Article en En | MEDLINE | ID: mdl-30651923
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: España